BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31033151)

  • 1. Plasma Exchange Is Highly Effective for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Patients With Rapidly Progressive Glomerulonephritis Who Have Advanced to Dialysis Dependence: A Single-Center Case Series.
    Nishida R; Kaneko S; Usui J; Kawamura T; Tsunoda R; Tawara T; Fujita A; Nagai K; Kai H; Morito N; Saito C; Yamagata K
    Ther Apher Dial; 2019 Jun; 23(3):253-260. PubMed ID: 31033151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Plasma Exchange in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Nishimura K; Waki D; Kadoba K; Mukoyama H; Yokota T; Murabe H
    Ther Apher Dial; 2019 Jun; 23(3):248-252. PubMed ID: 31033197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center.
    Li ZY; Gou SJ; Chen M; Zhao MH
    Semin Arthritis Rheum; 2013 Apr; 42(5):515-21. PubMed ID: 23332902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consideration of Therapeutic Plasma Exchange in Association With Inflammatory Lesions in ANCA-Associated Glomerulonephritis: A Real-World Retrospective Study From a Single Center.
    Tampe D; Ströbel P; Korsten P; Hakroush S; Tampe B
    Front Immunol; 2021; 12():645483. PubMed ID: 34220805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of an expanded use of plasma exchange for anti-neutrophil cytoplasmic antibody-associated vasculitis within a dedicated clinical service.
    Dhaun N; Saunders A; Bellamy CO; Gallardo RM; Manson L; Kluth DC
    BMC Musculoskelet Disord; 2015 Nov; 16():343. PubMed ID: 26552432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis.
    Walsh M; Catapano F; Szpirt W; Thorlund K; Bruchfeld A; Guillevin L; Haubitz M; Merkel PA; Peh CA; Pusey C; Jayne D
    Am J Kidney Dis; 2011 Apr; 57(4):566-74. PubMed ID: 21194817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange.
    Sagmeister MS; Weiss M; Eichhorn P; Habicht A; Habersetzer R; Fischereder M; Schönermarck U
    BMC Nephrol; 2018 Oct; 19(1):270. PubMed ID: 30340563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
    Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
    J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
    Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
    Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study.
    Chanouzas D; McGregor JAG; Nightingale P; Salama AD; Szpirt WM; Basu N; Morgan MD; Poulton CJ; Draibe JB; Krarup E; Dospinescu P; Dale JA; Pendergraft WF; Lee K; Egfjord M; Hogan SL; Harper L
    BMC Nephrol; 2019 Feb; 20(1):58. PubMed ID: 30777023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange in antineutrophil cytoplasm antibody-associated vasculitis.
    Walsh M
    Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):555-9. PubMed ID: 25144513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and outcome of pediatric ANCA-associated glomerulonephritis.
    Kouri AM; Andreoli SP
    Pediatr Nephrol; 2017 Mar; 32(3):449-455. PubMed ID: 27677979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group.
    de Luna G; Chauveau D; Aniort J; Carron PL; Gobert P; Karras A; Marchand-Adam S; Maurier F; Hatron PY; Mania A; le Guenno G; Bally S; Bienvenu B; Cardineau E; Goulenok T; Jourde-Chiche N; Samson M; Huart A; Pourrat J; Tiple A; Aumaitre O; Puéchal X; Heshmati F; le Jeunne C; Mouthon L; Guillevin L; Terrier B;
    J Autoimmun; 2015 Dec; 65():49-55. PubMed ID: 26330347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
    Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late restoration of renal function in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation.
    Ma TT; Liu YR; Chen M; Zhao MH
    Clin Rheumatol; 2018 Aug; 37(8):2143-2150. PubMed ID: 29679168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study.
    Xu PC; Chen T; Wu SJ; Yang X; Gao S; Hu SY; Wei L; Yan TK
    BMC Nephrol; 2019 Jul; 20(1):287. PubMed ID: 31362703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan.
    Hirayama K; Kobayashi M; Usui J; Arimura Y; Sugiyama H; Nitta K; Muso E; Wada T; Matsuo S; Yamagata K;
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i83-93. PubMed ID: 25613541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and temporal changes in the prognosis of rapidly progressive glomerulonephritis in Japan: a nationwide 1989-2015 survey.
    Kaneko S; Yamagata K; Usui J; Tsuboi N; Sugiyama H; Maruyama S; Narita I
    Clin Exp Nephrol; 2022 Mar; 26(3):234-246. PubMed ID: 34643841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exchange treatment in rapidly progressive glomerulonephritis associated with anti-neutrophil cytoplasmic autoantibodies.
    Frascà GM; Zoumparidis NG; Borgnino LC; Neri L; Vangelista A; Bonomini V
    Int J Artif Organs; 1992 Mar; 15(3):181-4. PubMed ID: 1521903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.